In this article, we will take a look at the Billionaire Larry Robbins’ 5 Dividend Stock Picks. For deeper discussion and analysis, read Billionaire Larry Robbins’ 10 Dividend Stock Picks.

5. Applied Materials, Inc. (NASDAQ:AMAT)

Glenview Capital’s Stake Value: $67,404,064

On June 11, Barclays raised the firm’s price recommendation on Applied Materials, Inc. (NASDAQ:AMAT) to $590 from $500. It reiterated an Overweight rating on the shares. Analyst Tom O’Malley increased his estimates for wafer fab equipment spending, saying the capital expenditure cycle is “much stronger across the board.” According to the analyst, sales exceeding $200 billion appear likely in 2027, though he noted that “the world has moved to 2028 already.”In a research note, O’Malley pointed to growing confidence in the industry’s long-term growth outlook.

A day earlier, on June 10, Cantor Fitzgerald raised its price goal on Applied Materials to $650 from $575. It maintained an Overweight rating on the stock. Cantor believes the semiconductor equipment industry is in the “early innings of a multi-year supply-constrained and durable upcycle.” The firm said the outlook has improved over the past three months, with booking visibility now beginning to extend into 2028. According to the analyst, leading-edge foundry and logic investments remain the primary drivers of wafer fab equipment growth. The majority of new wafer start investments in 2026 and 2027 are expected to be tied to AI-driven logic.

Applied Materials, Inc. (NASDAQ:AMAT) is a materials engineering solutions company. It provides equipment, services, and software to the semiconductor, display, and related industries. The company operates through two segments: Semiconductor Systems and Applied Global Services (AGS).

4. Meta Platforms, Inc. (NASDAQ:META)

Glenview Capital’s Stake Value: $70,178,610

On June 11, Bloomberg reported that Meta Platforms, Inc. (NASDAQ:META) had completed an operational split from Manus and stopped data sharing between the two companies. The move marks a significant step toward unwinding a $2 billion acquisition that Beijing has opposed.

According to people familiar with the matter, the owner of Facebook and Instagram has effectively created a firewall between itself and the Chinese-founded agentic AI service. The sources said Meta blocked Manus and its employees from accessing the company’s internal data systems at the beginning of the month. Meta employees can no longer use Manus tools for internal projects either. The people requested anonymity because the decisions are private.

The separation comes as Manus’s founders explore ways to meet Beijing’s demand to reverse the deal. One option under consideration is raising about $1 billion to finance a buyback.

According to an internal memo reviewed by Bloomberg News, Meta is “sunsetting” Manus. Employees were instructed to move existing Manus projects onto Meta’s own systems and avoid starting new work on the AI platform. The actions taken to separate the two operations represent another step toward eventually spinning off Manus, the people said.

Meta Platforms, Inc. (NASDAQ:META) is focused on building human connections through artificial intelligence and immersive technologies. Its products allow people to connect and share with friends and family through mobile devices, personal computers, virtual reality (VR) and mixed reality (MR) headsets, augmented reality (AR), and wearable devices.

3. Advanced Micro Devices, Inc. (NASDAQ:AMD)

Glenview Capital’s Stake Value: $132,390,617

On June 12, Citi upgraded Advanced Micro Devices, Inc. (NASDAQ:AMD) to Buy from Neutral. It also raised the firm’s price target to $575 from $460. The firm believes the upside from AMD’s graphics processing unit business is not fully reflected in the stock price. In a research note, analyst Atif Malik said AMD is “emerging as a legit second source” in the GPU market. Citi sees the company as well-positioned to capture the “lion’s share” of opportunities at Meta. The firm also believes investors continue to view AMD primarily as a central processing unit company, creating additional upside potential for the shares.

On June 11, BofA raised its price recommendation on AMD to $560 from $500. It reiterated a Buy rating. Based on the firm’s analysis and recent industry discussions at the BofA Global Tech Conference, it increased its calendar year 2030 server CPU total addressable market forecast to more than $170 billion from $125 billion. That implies nearly fivefold growth and a 37% compound annual growth rate between 2025 and 2030, according to the analyst.BofA views the emergence of agentic AI as a major demand driver that expands the CPU market opportunity and benefits both x86 incumbents and ARM challengers.

Advanced Micro Devices, Inc. (NASDAQ:AMD) is a global semiconductor company focused on high-performance computing and artificial intelligence (AI). The company operates through its Data Center, Client and Gaming, and Embedded segments.

2. Global Payments Inc. (NYSE:GPN)

Glenview Capital’s Stake Value: $428,054,382

On June 3, Mizuho analyst Dan Dolev said the weakness in Global Payments Inc. (NYSE:GPN) shares appeared to be driven by analyst commentary suggesting the company’s Q2 estimates might need to be revised lower. After reviewing the situation, Dolev said the concerns looked overstated. In a research note, he wrote, “Upon further investigation, we believe these worries are overblown.” The firm said it sees no reason to believe Global Payments will change its Q2 guidance. Mizuho also noted that the company reaffirmed its outlook at a conference two weeks earlier.

On June 11, TD Cowen lowered the firm’s price recommendation on Global Payments to $74 from $86. It reiterated a Hold rating on the stock. Analyst Bryan Bergin updated its model to reflect a more conservative view of previously communicated headwinds that now appear more likely to materialize. At the same time, TD Cowen said the company’s message around acceleration in the second half of 2026 remains unchanged.

Global Payments Inc. (NYSE:GPN) is a payment technology and software company that powers commerce for businesses of all sizes around the world.

1. CVS Health Corporation (NYSE:CVS)

Glenview Capital’s Stake Value: $588,694,104

On June 4, Morgan Stanley raised its price recommendation on CVS Health Corporation (NYSE:CVS) to $111 from $106. It reiterated an Overweight rating on the shares. The analyst noted that managed care stocks have been “grinding higher” as signs of softer utilization trends begin to emerge. Morgan Stanley also examined the potential impact of artificial intelligence on managed care organizations, saying AI could support both revenue growth and cost reductions. According to the firm, those efficiencies could eventually generate about 45% average EPS upside as they scale over time.

On June 8, Mizuho raised its price goal on CVS to $115 from $110. It kept an Outperform rating on the stock. The firm believes the managed care sector is moving into a “more stable and predictable” policy environment. In a research note, the analyst said the magnitude and frequency of policy-related surprises are likely to ease from the elevated levels seen over the past three years. That shift could allow investors to focus more on company fundamentals, pricing recovery, and the sector’s underlying earnings power. Mizuho also increased price targets across the sector to reflect what it views as a more stable regulatory and legislative backdrop.

CVS Health Corporation (NYSE:CVS) is a health solutions company. Its operations are organized into four segments: Health Care Benefits, Health Services, Pharmacy & Consumer Wellness, and Corporate/Other.

READ NEXT: 10 Best S&P 500 Dividend Stocks to Buy Right Now and 10 Best Value Dividend Stocks to Buy Now According to Warren Buffett

Disclosure: None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below.